Internal Medicine Board Review
- - The elevated peripheral white blood count
    David L. Longworth, MD, James K. Stoller, MD and Brian J. Bolwell, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 267-268;
Highlights from Medical Grand Rounds
- - Parkinson’s disease: where do westand?
    William S. Wilke, MD and Patrick J. Sweeney, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 269-270;
    Although a cure has not been found, certain drugs can relieve symptoms and may actually slow disease progression.
  - Irritable bowel syndrome: new perspectives on management
    Marvin M. Schuster, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 270-272;
    Long classified as psychosomatic, irritable bowel syndrome is now considered a motor disorder in which a number of factors are at play.
Current Drug Therapy
- - The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: insights and highlights from the chairman
    Donald G. Vidt, MD, Alan Bakst, PharmD and Ray W. Gifford Jr, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 273-277;
    Highlights include the new classification schema and recommendations on the use of labetalol.
  - Assessing hypertension management: the role of 24-hour blood pressure monitoring
    Donald G. Vidt, MD, Alan Bakst, Pharmd, Beatriz Esayag-Tendler, MD and William B. White, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 278-283;
    BACKGROUND
    The first fully automatic portable invasive blood pressure recorder was developed 30 years ago. Today, portable noninvasive ambulatory blood pressure devices are capable of measuring blood pressure intermittently for periods of 24 to 48 hours.
  - From bathtub ring to osteoporosis: a clinical review of the bisphosphonates
    Donald G. Vidt, MD, Alan Bakst, PharmD and Angelo A. Licata, MD, PhD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 284-290;
    BACKGROUND
    Etidronate and pamidronate are bisphosphonates, a class of chemical compounds originally used to soften hard water and prevent soap scum. Etidronate was serendipitously found to abate calcification in a child with myositis ossificans progressiva.
  - The use of G-CSF and GM-CSF in bone marrow transplantation
    Donald G. Vidt, MD, Alan Bakst, PharmD and Brian J. Bolwell, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 291-302;
    Using hematopoietic growth factors appears to have made bone marrow transplantation safer. Treatment-related morbidity and mortality have decreased, and patients are discharged from the hospital sooner.
Original Study
- - Lung transplantation: the Cleveland Clinic experience
    Sunit R. Patel, MD, Thomas J. Kirby, MD, Patrick M. McCarthy, MD, David P. Meeker, MD, Paul Stillwell, MD, Thomas W. Rice, MD, Mani S. Kavuru, MD and Atul C. Mehta, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 303-319;
    BACKGROUND
    Lung transplantation has been steadily developing as a therapeutic option for end-stage lung disease.
  - Stereotactically guided thrombolysis of deep cerebral hemorrhage: preliminary results
    David W. Miller, MD, Gene H. Barnett, MD, Donald W. Kormos, PhD and Charles P. Steiner, BS
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 321-324;
    BACKGROUND
    The neurologic outcome from conventional medical or surgical therapy of intracerebral hemorrhage (ICH) is poor; however, stereotactically guided instillation of thrombolytic agents to dissolve parenchymal clots due to hypertensive hemorrhage has recently produced results equal to or better than those obtained with conventional therapies.
Review
- - The pulmonary effects of free-base cocaine: a review
    Ira S. Meisels, MD and Jacob Loke, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 325-329;
    Respiratory symptoms, pulmonary hemorrhage, pulmonary edema, asthma, pulmonary barotrauma, and other pulmonary effects of free-base cocaine are reviewed.
  - Parathyroid carcinoma: 50-year experience at The Cleveland Clinic Foundation
    Albert G. Hakaim, MD, MSc and Caldwell B. Esselstyn Jr, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 331-335;
    BACKGROUND
    Parathyroid carcinoma is rare, with a reported prevalence of 0.6% to 4.0% in patients presumed to have primary hyperparathyroidism. This study examines the long-term results of surgical therapy and combination chemotherapy.
Case Report
- - Hemopericardium and cardiac tamponade associated with warfarin therapy
    Kamthorn S. Lee, MD and Thomas Marwick, MD
    Cleveland Clinic Journal of Medicine July 1993, 60 (4) 336-338;

In this issue

Sign up for alerts

Table of Contents

Internal Medicine Board Review

The elevated peripheral white blood count

Highlights from Medical Grand Rounds

Parkinson’s disease: where do westand?

Irritable bowel syndrome: new perspectives on management

Current Drug Therapy

The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: insights and highlights from the chairman

Assessing hypertension management: the role of 24-hour blood pressure monitoring

From bathtub ring to osteoporosis: a clinical review of the bisphosphonates

The use of G-CSF and GM-CSF in bone marrow transplantation

Original Study

Lung transplantation: the Cleveland Clinic experience

Stereotactically guided thrombolysis of deep cerebral hemorrhage: preliminary results

Review

The pulmonary effects of free-base cocaine: a review

Parathyroid carcinoma: 50-year experience at The Cleveland Clinic Foundation

Case Report

Hemopericardium and cardiac tamponade associated with warfarin therapy

In this issue

Cleveland Clinic Journal of Medicine

Jump to